7Kurihara C, Matsumoto K, Mitsuishi T. The revised Japanese pharmaceutical law and research ethics: Risk-benefit assessment of fetal stem cell research. Journal of the Pharmaceutical Society.2003;123(3):91-106.
8Martin PA, Coveney C, Kraft A, et al. Commercial development of stem cell technology: lessons from the past, strategies for the future. gen Med. 2006;1(6):801-807.
9Matthews KR, Rowland ML. Stem cell policy in the Obama age: UK and US perspectives. Regen Med. 2011;6(1):125-132.
10Bates SR, Faulkner W, Parry S, et al. How do we know it's not been done yet?! Trust, trust building and regulation in stem cell research. Science and Public Policy.2010; 37(9):703-718.
